empagliflozin/linagliptin
General
**BEERS Drug**
Pronunciation: 
em-pa-gli-floe-zin/lin-a-glip-tin
 To hear audio pronunciation of this topic, purchase a subscription or log in.
To hear audio pronunciation of this topic, purchase a subscription or log in.Trade Name(s)
- Glyxambi
Ther. Class.
Pharm. Class.
sodium-glucose co-transporter 2 (SGLT2) inhibitors
dipeptidyl peptidase-4 (DDP-4) inhibitors
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Empagliflozin/linagliptin." Davis's Drug Guide, 19th ed., F.A. Davis Company, 2025. Nursing Central, nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/110361/all/empagliflozin_linagliptin. 
Vallerand AHA, Sanoski CAC,  . Empagliflozin/linagliptin. Davis's Drug Guide. F.A. Davis Company; 2025. https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/110361/all/empagliflozin_linagliptin. Accessed October 31, 2025.
Vallerand, A. H., Sanoski, C. A., & ,  (2025). Empagliflozin/linagliptin. In Davis's Drug Guide (19th ed.). F.A. Davis Company. https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/110361/all/empagliflozin_linagliptin
Vallerand AHA, Sanoski CAC,  . Empagliflozin/linagliptin [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2025. [cited 2025 October 31]. Available from: https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/110361/all/empagliflozin_linagliptin.
* Article titles in AMA citation format should be in sentence-case
TY  -  ELEC
T1  -  empagliflozin/linagliptin
ID  -  110361
A1  -  Sanoski,Cynthia A,
AU  -  Vallerand,April Hazard,
AU  -  ,,
BT  -  Davis's Drug Guide
UR  -  https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/110361/all/empagliflozin_linagliptin
PB  -  F.A. Davis Company
ET  -  19
DB  -  Nursing Central
DP  -  Unbound Medicine
ER  -  

 Davis's Drug Guide
Davis's Drug Guide

